SINGAPORE, 14 APRIL 2022: Us2.ai, the Singapore-based medtech developers of FDA- cleared AI software that, for the first time ever, fully automates a complete echocardiography (heart ultrasound) report, today announced...
TargeGen closes on $40 million venture round
News | 07. 12. 2007
TargeGen
TargeGen, Inc. has announced that the Company has successfully closed a $40M venture round of financing.
